跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NORMOTUS EXPECTORANTE 2 MG/ML + 20 MG/ML SOLUCION ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
NORMOTUS EXPECTORANTE 2 MG/ML + 20 MG/ML SOLUCION ORAL
Approved
STANDARD
NORMOTUS EXPECTORANTE 2 MG/ML + 20 MG/ML SOLUCION ORAL
Laboratorios Normon S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 11, 2023
Approval ID
a4dd7ac5d5367f43
Company
Laboratorios Normon S.A.
Type
Standard
Approval Details
Approval Id
a4dd7ac5d5367f43
Drug Cima Aemps Name
NORMOTUS EXPECTORANTE 2 MG/ML + 20 MG/ML SOLUCION ORAL
Register Number
88958
Holder Company Name
Laboratorios Normon S.A.
Marketing Company Name
Laboratorios Normon S.A.
Authorization Date
2023-07-11
Dosage Form
SOLUCIÓN ORAL
Dose
2 mg/ml + 20 mg/ml
Route Of Administration
VÍA ORAL
Prescription Type
Sin Receta
Commercialized
Yes
Company Name
Laboratorios Normon S.A.
Active Ingredients
DEXTROMETORFANO HIDROBROMURO
2 mg/ml
GUAIFENESINA
20 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 11, 2023
Approval ID
a4dd7ac5d5367f43
Type
Standard
Back to CIMA-AEMPS Approvals